Principal Investigator
Alfonso Sabater
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20211165
Clinical Trial Summary
Beremagene geperpavec (B-VEC, KB103) for the treatment of recurrent corneal conjunctivalization in the context of epidermolysis bullosa (EB)
Phase
N/A
Funding Agency/Sponsor
Intramural
Disease
Other
Contact Information
Study Contact
Javier Paredes
Phone Number
+1 (305) 3266387
Email
jxp2537@miami.edu